P140026S020

None

FDA Premarket Approval P140026 S020

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP140026S020
Classification NameNone
Applicant
PMAP140026
SupplementS020

Supplemental Filings

Supplement NumberDateSupplement Type
P140026Original Filing
S021 2022-06-13 30-day Notice
S020
S019 2022-04-22 30-day Notice
S018 2021-04-05 30-day Notice
S017 2021-03-05 Special (immediate Track)
S016
S015 2020-05-18 30-day Notice
S014 2019-12-17 Normal 180 Day Track No User Fee
S013 2019-08-05 30-day Notice
S012 2019-04-05 30-day Notice
S011 2018-12-04 30-day Notice
S010 2018-04-23 Normal 180 Day Track No User Fee
S009 2018-04-02 30-day Notice
S008 2018-01-29 30-day Notice
S007
S006 2017-02-14 Normal 180 Day Track No User Fee
S005 2017-01-31 Normal 180 Day Track
S004 2017-01-09 30-day Notice
S003 2016-06-08 30-day Notice
S002 2016-03-07 Normal 180 Day Track No User Fee
S001 2015-06-05 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00811311020539 P140026 000
00811311020379 P140026 000
00811311020386 P140026 000
00811311020393 P140026 000
00811311020409 P140026 000
00811311020416 P140026 000
00811311020423 P140026 000
00811311020430 P140026 000
00811311020447 P140026 000
00811311020454 P140026 000
00811311020461 P140026 000
00811311020478 P140026 000
00811311020485 P140026 000
00811311020492 P140026 000
00811311020508 P140026 000
00811311020515 P140026 000
00811311020522 P140026 000
00811311020362 P140026 000

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.